myopia
Conditions
Interventions
Experimental group:Wear myopic frame glasses (optical monocal lens) + BBL myopia amblyopia comprehensive treatment instrument
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
6 Years to 18 Years
Inclusion criteria
Inclusion criteria: 1. Age at enrollment>=6,<18 years old; 2. Diagnosed as nearsighted according to the "Guidelines for the Prevention and Treatment of Myopia" issued by the National Health Commission (National Health Office Medical Letter [2018] No. 393); 3. Refraction after bilateral ciliary muscle paralysis -6.00D < SE<=-0.75D; 4. anisometropia < 1.5D; 5. Use a comprehensive treatment device for myopia and amblyopia (model: BBL2020-01); 6. The subjects and their guardians can understand this study, sign an informed consent form, and cooperate with treatment and relevant ophthalmic examinations.
Exclusion criteria
Exclusion criteria: 1. strabismus and/or amblyopia; 2. Tumor, heart disease, hypertension, epilepsy, etc.; 3. Use of implantable electronic devices (e.g., pacemakers); 4. Photophobia or inability to open eyes normally due to keratitis, trichiasis, trauma, etc.; 5. Subjects with systemic diseases: history of immune system diseases, central nervous system diseases, Down syndrome, asthma, severe cardiopulmonary function, severe liver and kidney dysfunction; 6. Previous use or concurrent use of atropine ophthalmology, and previous use of red light therapeutic apparatus; 7. Suffer from eye diseases that affect vision or refractive error (such as cataract and other lens damage diseases, glaucoma, macular disease, keratopathy, pigmentosis, retinal detachment, severe vitreous opacity, etc.); 8. Internal or external use of photosensitive drugs, photosensitive diseases, solar dermatitis, mentally unhealthy subjects, pregnant women, etc.; 9. Have worn bifocal glasses, progressive multifocal glasses, orthokeratology glasses, multifocal contact lenses or other functional lenses within 3 months; 10. The therapeutic apparatus is not applicable after evaluation by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| axial lengths; | — |
Secondary
| Measure | Time frame |
|---|---|
| diopter;Choroidal thickness; | — |
Countries
China
Contacts
Public ContactLiu Longqian
West China Hospital of Sichuan University
Outcome results
None listed